 | Up a level |
Framme, C; Wolf-Schnurrbusch, U E K; Lobsiger, H; Bayer, S; Wolf, S (2012). [Adapted and Standardised Patient Management in the Treatment of Neovascular AMD in the Outpatient Setting of a University Eye Hospital.]. Klinische Monatsblätter für Augenheilkunde, 229(8), pp. 812-21. Stuttgart: Ferdinand Enke Verlag 10.1055/s-0031-1299405
Fleckenstein, M; Wolf-Schnurrbusch, U; Wolf, S; von Strachwitz, C; Holz, F G; Schmitz-Valckenberg, S (2010). [Imaging diagostics of geographic atrophy]. Ophthalmologe, 107(11), pp. 1007-15. Heidelberg: Springer-Medizin-Verlag 10.1007/s00347-010-2159-y
Soubrane, G; Harding, S P; Wolf, S; Weichselberger, A (2009). Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study. Eye, 23(4), pp. 791-800. London: Nature Publishing Group 10.1038/eye.2008.158
Schmidt-Erfurth, U; Wolf, S (2008). Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration. British journal of ophthalmology, 92(12), pp. 1628-35. London: BMJ Publishing Group 10.1136/bjo.2007.135277
Wolf, S (2007). Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia. British journal of ophthalmology, 91(6), pp. 706-707. London: BMJ Publishing Group 10.1136/bjo.2007.114033
Iliev, ME; Bodmer, S; Gallati, S; Lanz, R; Sturmer, J; Katsoulis, K; Wolf, S; Trittibach, P; Sarra, GM (2007). Glaucoma phenotype in a large Swiss pedigree with the myocilin Gly367Arg mutation. Eye, 22(7), pp. 880-888. London: Nature Publishing Group 10.1038/sj.eye.6702745
Feltgen, N; Weiss, C; Wolf, S; Ottenberg, D; Heimann, H; Study Group, SPR (2007). Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2. Graefe's archive for clinical and experimental ophthalmology, 245(6), pp. 803-9. Berlin: Springer 10.1007/s00417-006-0399-y
Wolf, S (2006). Macular pigment measurements: which method should we use? Graefe's archive for clinical and experimental ophthalmology, 244(12), pp. 1562-1564. Berlin: Springer-Verlag 10.1007/s00417-006-0336-0
Schmitz-Valckenberg, S; Bindewald-Wittich, A; Dolar-Szczasny, J; Dreyhaupt, J; Wolf, S; Scholl, HP; Holz, FG; Fundus, Autofluorescence in Age-Related Macular Degeneration Study Group (2006). Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Investigative ophthalmology & visual science, 47(6), pp. 2648-54. Hagerstown, Md.: Association for Research in Vision and Ophthalmology 10.1167/iovs.05.0892
Jahn, C; Brinkmann, C; Mössner, A; Wüstemeyer, H; Schnurrbusch, U; Wolf, S (2006). [Seasonal fluctuations and influence of nutrition on macular pigment density]. Ophthalmologe, 103(2), pp. 136-40. Heidelberg: Springer-Verlag 10.1007/s00347-005-1282-7
Chakravarthy, U; Soubrane, G; Bandello, F; Chong, V; Creuzot-Garcher, C; Korobelnik, J-F; Larsen, M; Monés, J; Pauleikhoff, D; Staurenghi, G; Virgili, G; Wolf, S (2006). Evolving European guidance on the medical management of neovascular age related macular degeneration. British journal of ophthalmology, 90(9), pp. 1188-1196. London: BMJ Publishing Group 10.1136/bjo.2005.082255
Rudolph, T; Bröhan, AM; Amstutz, CA; Wolf, S; Kowal, JH (2011). Validation of a real-time retinal image registration method for a computer assisted laser photocoagulation system. In: Fort Lauderdale, USA.
Wolf-Schnurrbusch, U; Brinkmann, Ch; Berger, L; Wolf, S (2008). Kombinationstherapie bei exsudativer AMD Kurzzeitergebnisse einer Studie mit PDT und Ranibizumab.
